Broadcast Date: 
  • Time: 

Cell culture is the unsung workhorse of biopharmaceutical drug development, yet it is so often the essential backbone of discovery projects. The growth of cells in laboratory settings constitutes a wide assortment of factors for their appropriate growth, with environmental conditions raking at the top of the list of importance. Reliable incubator technology is critical to yielding the high-quality results investigators are constantly seeking. Moreover, with respect to GMP, incubator technology must include algorithmic control systems and safeguards designed to protect the cell culture or cell-expressed product, particularly when associated with direct human applications such as cell-derived biologics and whole-cell therapies. 

In this GEN webinar, we will discuss the “other side” of cell and biologic production that doesn’t require stirred bioreactors. Furthermore, we will explore different cell expression platforms that enable various cell-based manufacturing within the small and medium-range scale of production. Finally, our webinar panelists will show us how the design of incubation systems should support both clinical and pharmaceutical applications, starting with research and leading to development, manufacturing, and scale-up.

A live Q&A session followed the presentations, offering you a chance to pose questions to our expert panelists.


Webinar produced with support from:

PHCbi logo
Holly Hattaway
Holly Hattaway
Incubator Product Specialist